#3 BETHESDA METRO CENTRE

SUITE 700

BETHESDA, MD 20814

---------

Tel (877) 424-2429

Cannabics.com

14^th October, 2015

US Securities & Exchange Commission

Corporate Finance Division

Washington, DC 20549

Attn: Ms. Julie Marlowe

Re: Cannabics Pharmaceuticals Inc.

Form 10-K for the Fiscal Year Ended August 31, 2014

Filed December 15, 2014

File No. 000-52403

Dear Ms. Marlowe,

The Issuer has been preparing its responses to your above-referenced Comments. We are aware of the time delay and now finalizing our last section, which was given out for 3^rd party opinion.

We would expect to have these responses presented to you no later than Tuesday, October 20^th. Should you have any questions or comments, please do contact me at any time. Thank you for your understanding in this matter.

Sincerely yours,

/s/ David E. Price

David E. Price, Esq.